Literature DB >> 1099399

Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital.

S C Deresinski, D A Stevens.   

Abstract

To determine the frequency and clinical characteristics of infection with Coccidioides immitis in immunosuppressed patients at Stanford University Hospital, clinical records of 14 years were examined. Thirteen cases met the diagnostic criteria. Half had Hodgkin's disease. In six the infection was disseminated; five of the six died early in the course of their infectious illness, frequently without diagnosis. Conclusions include: 1. The occurrence of coccidioidomycosis in immunosuppressed patients seen at institutions in or adjacent to the endemic area is not as rare as the literature suggests. 2. Dissemination is frequently explosive and the radiographic appearance of pulmonary involvement may appear late. Widespread pulmonary dissemination may occur within 24 hours after a negative x-ray. 3. Although the skin test loses its diagnostic value, the serology remains valid. Thus immunosuppressed patients with febrile illnesses (with or without radiographically evident pulmonary involvement) who have a history of travel to an endemic area should have serological examinations. 4. Lymphocytopenia correlates with risk of dissemination of coccidioidomycosis. 5. The administration of immunsuppressive chemotherapy correlates with such risk while radiotherapy and the malignant or non-malignant nature of the disease do not.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1099399     DOI: 10.1097/00005792-197509000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  19 in total

Review 1.  Fungal arthritis.

Authors:  M L Cuéllar; L H Silveira; L R Espinoza
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  An immunoreactive apoglycoprotein purified from Coccidioides immitis.

Authors:  K O Dugger; J N Galgiani; N M Ampel; S H Sun; D M Magee; J Harrison; J H Law
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome.

Authors:  A Kovacs; D N Forthal; J A Kovacs; G D Overturf
Journal:  West J Med       Date:  1984-03

Review 4.  Serology of coccidioidomycosis.

Authors:  D Pappagianis; B L Zimmer
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

Review 5.  Coccidioidomycosis.

Authors:  D A Bronnimann; J N Galgiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

6.  Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.

Authors:  Janis E Blair; Brandon Coakley; Ana C Santelli; Joseph G Hentz; Nancy L Wengenack
Journal:  Mycopathologia       Date:  2006-11       Impact factor: 2.574

Review 7.  Coccidioidomycosis.

Authors:  J N Galgiani
Journal:  West J Med       Date:  1993-08

8.  Problems in antifungal chemotherapy.

Authors:  D A Stevens
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

9.  Reactivity to spherule-derived coccidioidin in the southeastern United States.

Authors:  W W Woodruff; C E Buckley; H A Gallis; J R Cohn; R W Wheat
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  Immunodiagnosis of candida-infections. I. Sensitivity of the antigens.

Authors:  A Tomsíková; J Sach; V Zavázal; L Masler; D Nováckova
Journal:  Mycopathologia       Date:  1980-07-01       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.